Open AccessAT-1 receptor antagonism with candesartan cilexitil improves endothelial function in patients with hypertension and coronary artery disease: A double-blind, randomized, placebo-controlled trial
Author(s) -
P. Pasquale Perrone Filardi,
Gregorio Brevetti,
Antonio Silvestro,
Luigi Corrado,
Maria Assunta Cafiero,
Andrea Petretta,
Gianluca Caiazzo,
Michele Polimeno,
A. Zarrilli,
Roberta Camerino
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.196
Subject(s) - medicine , candesartan , coronary artery disease , cardiology , placebo , endothelial dysfunction , adverse effect , disease , randomized controlled trial , blood pressure , angiotensin ii , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom